These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37066690)

  • 21. Methylphenidate Treats Apathy in Alzheimer Disease.
    Slomski A
    JAMA; 2021 Dec; 326(21):2120. PubMed ID: 34874434
    [No Abstract]   [Full Text] [Related]  

  • 22. Methylphenidate for Apathy in Alzheimer Disease-Why Should We Care?
    Fredericks C
    JAMA Neurol; 2021 Nov; 78(11):1311-1313. PubMed ID: 34570178
    [No Abstract]   [Full Text] [Related]  

  • 23. Improvement of neuronal integrity with methylphenidate treatment for apathy in Alzheimer's disease.
    Padala PR; Padala KP; Samant RS; James GA
    Int Psychogeriatr; 2020 Apr; 32(4):539-540. PubMed ID: 32019622
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.
    Frakey LL; Salloway S; Buelow M; Malloy P
    J Clin Psychiatry; 2012 Jun; 73(6):796-801. PubMed ID: 22687392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The law of diminishing intent: getting excited about apathy.
    Porsteinsson AP; Hasselberg MJ
    J Clin Psychiatry; 2013 Aug; 74(8):817-8. PubMed ID: 24021499
    [No Abstract]   [Full Text] [Related]  

  • 26. My wife has moderate Alzheimer's disease. It's difficult to get her to perform even the simplest task for herself. How can I best deal with her apathy?
    Duke Med Health News; 2012 Apr; 18(4):8. PubMed ID: 22545280
    [No Abstract]   [Full Text] [Related]  

  • 27. Methylphenidate may treat apathy independent of depression.
    Padala PR; Petty F; Bhatia SC
    Ann Pharmacother; 2005 Nov; 39(11):1947-9. PubMed ID: 16204387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial.
    Maier F; Spottke A; Bach JP; Bartels C; Buerger K; Dodel R; Fellgiebel A; Fliessbach K; Frölich L; Hausner L; Hellmich M; Klöppel S; Klostermann A; Kornhuber J; Laske C; Peters O; Priller J; Richter-Schmidinger T; Schneider A; Shah-Hosseini K; Teipel S; von Arnim CAF; Wiltfang J; Jessen F
    JAMA Netw Open; 2020 May; 3(5):e206027. PubMed ID: 32463470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of apathy with methylphenidate.
    Padala PR; Burke WJ; Bhatia SC; Petty F
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):81-3. PubMed ID: 17308232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of apathy in the effectiveness of weight management programmes.
    Desouza CV; Padala PR; Haynatzki G; Anzures P; Demasi C; Shivaswamy V
    Diabetes Obes Metab; 2012 May; 14(5):419-23. PubMed ID: 22145671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylphenidate in a patient with Alzheimer's disease : Increase in drive and cardiac performance].
    Schuhfried G; Schuhfried G
    Z Gerontol Geriatr; 2017 Jun; 50(4):362-364. PubMed ID: 27075452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
    Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
    Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
    Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
    Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylphenidate and Apathy in Alzheimer's Disease: Is Sleep Apnea a Confounding Effect?
    Kolla BP; Mansukhani MP
    Am J Psychiatry; 2018 Aug; 175(8):792. PubMed ID: 30064252
    [No Abstract]   [Full Text] [Related]  

  • 37. Addressing Possible Effects of Sleep Apnea in a Study of Methylphenidate for Apathy in Alzheimer's Disease: Response to Kolla and Mansukhani.
    Padala PR; Dennis RA; Padala KP
    Am J Psychiatry; 2018 Aug; 175(8):792-793. PubMed ID: 30064247
    [No Abstract]   [Full Text] [Related]  

  • 38. A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
    Banerjee S; Farina N; Henderson C; High J; Stirling S; Shepstone L; Fountain J; Ballard C; Bentham P; Burns A; Fox C; Francis P; Howard R; Knapp M; Leroi I; Livingston G; Nilforooshan R; Nurock S; O'Brien J; Price A; Thomas AJ; Swart AM; Telling T; Tabet N
    Health Technol Assess; 2023 Oct; 27(23):1-108. PubMed ID: 37929672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological Management of Apathy in Dementia.
    Azhar L; Kusumo RW; Marotta G; Lanctôt KL; Herrmann N
    CNS Drugs; 2022 Feb; 36(2):143-165. PubMed ID: 35006557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.